Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Usually worst during dose increases and improves as the body adjusts
Some programs hand you a prescription and disappear
Retatrutide Side Effects (Preliminary Data) Common (from Phase 2 data): Nausea (25-45% depending on dose) Diarrhea (20-35%) Vomiting (10-20%) Constipation (10-15%) Decreased appetite Notable differences: Mild increases in resting heart rate observed The glucagon receptor component may introduce metabolic effects not seen with GLP-1-only medications Full safety profile awaiting Phase 3 data The overall tolerability of retatrutide in the Phase 2 trial was described as acceptable, with most adverse events being mild to moderate
Why is the body not producing enough GLP-1, or not responding to it
Side effects unrelated to injection technique Not everything is about technique
At Passion Health Advanced Primary Care, the goal is to help patients understand whether Ozempic is medically appropriate, financially realistic, and safe for long-term care
